104 results
8-K
EX-99.1
IRWD
Ironwood Pharmaceuticals Inc - Ordinary Shares
15 Feb 24
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
7:04am
assets. Building upon our history of GI innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI
8-K
EX-99.1
IRWD
Ironwood Pharmaceuticals Inc - Ordinary Shares
8 Jan 24
Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance
6:05am
, including short bowel syndrome with intestinal failure (SBS-IF) as well as several earlier stage assets. Building upon our history of GI innovation, we keep
8-K
EX-99.2
IRWD
Ironwood Pharmaceuticals Inc - Ordinary Shares
8 Jan 24
Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance
6:05am
patients
Leading the Way in GI Innovation Ironwood is uniquely positioned to drive value as a GI - focused biotech with multiple 2024 development
8-K
EX-99.1
qb3 sbmiq
9 Nov 23
Ironwood Pharmaceuticals Reports Third Quarter 2023 Results
7:07am
8-K/A
EX-99.1
tc4h8lu
11 Sep 23
Index to Financial Statements
4:30pm
8-K
EX-99.1
djgs kzaol1oz8
8 Aug 23
Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance
7:08am
8-K
EX-99.1
0b5gj5pv0njbfs5m0so
30 Jun 23
Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares
4:05pm
SC TO-T/A
EX-99
2au8 nlh1fkh
29 Jun 23
Third party tender offer statement (amended)
8:32am
SC TO-T/A
EX-99
3umpd78wbgzuk
16 Jun 23
Third party tender offer statement (amended)
7:09am
SC TO-T
EX-99
ks3l 6gg3sy
31 May 23
Third party tender offer statement
6:46am
SC TO-C
EX-99.4
kvxz3is0b5d0rc4
22 May 23
Information about tender offer
5:00pm
SC TO-C
EX-99.1
cn31gv4j m9aq0p
22 May 23
Information about tender offer
5:00pm
SC TO-C
EX-99.5
0twkxntaoo vxq81f7h
22 May 23
Information about tender offer
5:00pm
SC TO-C
EX-99.2
e77kzqszo8xm1
22 May 23
Information about tender offer
4:26pm
8-K
EX-99.2
7tj08huqsx8i8s4oa
22 May 23
Entry into a Material Definitive Agreement
4:25pm
8-K
EX-99.1
fct 46cf44ap8sx
4 May 23
Ironwood Pharmaceuticals Reports First Quarter 2023 Results; Maintains Full Year 2023 Financial Guidance
7:12am